Hiramatsu M, Inoue K
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan.
Eur J Pharmacol. 1999 Feb 19;367(2-3):151-5. doi: 10.1016/s0014-2999(99)00003-5.
We investigated the effects of nociceptin/orphanin FQ and nocistatin on learning and memory function as measured in a step-down type passive avoidance task and spontaneous alternation of Y-maze with mice. Nociceptin (0.5-5.0 nmol/mouse, i.c.v.) 30 min before the training session or Y-maze test, dose dependently shortened the step-down latency and impaired spontaneous alternation, while there was no significant effect of nocistatin (0.5-5.0 nmol/mouse). Interestingly, nocistatin (5.0 nmol) significantly improved the nociceptin (5.0 nmol)-induced impairment of learning and memory without changing motor activity or response to electric shocks. These results suggest that nocistatin, a new biologically active peptide now found to also counteract the impairment of learning and memory induced by nociceptin, plays an important role in the regulation of learning and memory process in the central nervous system.
我们研究了痛敏肽/孤啡肽FQ和痛抑素对小鼠在一步跳下式被动回避任务及Y迷宫自发交替实验中所测学习和记忆功能的影响。在训练或Y迷宫测试前30分钟,脑室内注射痛敏肽(0.5 - 5.0 nmol/小鼠),剂量依赖性地缩短了一步跳下潜伏期并损害了自发交替,而痛抑素(0.5 - 5.0 nmol/小鼠)无显著影响。有趣的是,痛抑素(5.0 nmol)显著改善了痛敏肽(5.0 nmol)诱导的学习和记忆损害,且不改变运动活性或对电击的反应。这些结果表明,痛抑素作为一种新发现的具有生物活性的肽,现在发现它还能抵消痛敏肽诱导的学习和记忆损害,在中枢神经系统学习和记忆过程的调节中起重要作用。